Shares of Trupanion, Inc. (NASDAQ:TRUP – Get Free Report) have been given an average recommendation of “Hold” by the six ratings firms that are covering the stock, Marketbeat Ratings reports. One research analyst has rated the stock with a sell recommendation, three have given a hold recommendation and two have assigned a buy recommendation to the company. The average 12 month price objective among brokers that have issued ratings on the stock in the last year is $41.50.
TRUP has been the subject of several analyst reports. Bank of America reduced their price target on shares of Trupanion from $63.00 to $59.00 and set a “buy” rating for the company in a report on Tuesday, April 14th. Cantor Fitzgerald reduced their price target on shares of Trupanion from $42.00 to $34.00 and set a “neutral” rating for the company in a report on Thursday, April 9th. Stifel Nicolaus set a $28.00 price target on shares of Trupanion in a report on Friday. Finally, Weiss Ratings reissued a “sell (d+)” rating on shares of Trupanion in a report on Monday, June 1st.
Check Out Our Latest Research Report on TRUP
Trupanion Stock Performance
Trupanion (NASDAQ:TRUP – Get Free Report) last released its quarterly earnings data on Thursday, April 30th. The financial services provider reported $0.11 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.07 by $0.04. Trupanion had a return on equity of 6.87% and a net margin of 1.74%.The business had revenue of $384.05 million during the quarter, compared to analyst estimates of $379.77 million. During the same quarter in the previous year, the firm posted ($0.03) EPS. The business’s revenue for the quarter was up 12.3% compared to the same quarter last year. Research analysts expect that Trupanion will post 0.54 earnings per share for the current year.
Insider Activity
In other news, EVP Steve Weinrauch sold 6,674 shares of the business’s stock in a transaction on Friday, June 5th. The shares were sold at an average price of $22.00, for a total transaction of $146,828.00. Following the completion of the transaction, the executive vice president owned 78,062 shares of the company’s stock, valued at approximately $1,717,364. The trade was a 7.88% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, CFO Fawwad Qureshi sold 6,177 shares of the company’s stock in a transaction dated Wednesday, May 27th. The stock was sold at an average price of $22.18, for a total transaction of $137,005.86. Following the completion of the sale, the chief financial officer directly owned 2,081 shares of the company’s stock, valued at $46,156.58. The trade was a 74.80% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Over the last quarter, insiders sold 17,806 shares of company stock valued at $395,508. 5.58% of the stock is currently owned by company insiders.
Institutional Investors Weigh In On Trupanion
Institutional investors have recently bought and sold shares of the stock. Kelleher Financial Advisors acquired a new stake in Trupanion in the third quarter worth about $74,000. Kemnay Advisory Services Inc. acquired a new stake in Trupanion in the fourth quarter worth about $64,000. Parallel Advisors LLC lifted its holdings in Trupanion by 1,831.9% in the first quarter. Parallel Advisors LLC now owns 1,816 shares of the financial services provider’s stock worth $47,000 after purchasing an additional 1,722 shares during the period. PNC Financial Services Group Inc. lifted its holdings in Trupanion by 21.7% in the third quarter. PNC Financial Services Group Inc. now owns 2,678 shares of the financial services provider’s stock worth $116,000 after purchasing an additional 478 shares during the period. Finally, Advisory Services Network LLC acquired a new stake in Trupanion in the third quarter worth about $160,000.
About Trupanion
Trupanion, Inc is a pet medical insurance company that provides comprehensive insurance coverage for cats and dogs. The company’s core offering is a single, customizable medical policy designed to cover veterinary diagnostic tests, surgeries, hospital stays and congenital or hereditary conditions. Trupanion seeks to streamline the claims process by offering direct payment options to participating veterinarians, reducing the need for upfront payments by pet owners.
Founded in 1999 by Darryl Rawlings and headquartered in Seattle, Washington, Trupanion began operations in the early 2000s and has grown its presence through both digital channels and partnerships with veterinary hospitals.
Read More
- Five stocks we like better than Trupanion
- 3 Stocks That Could Benefit as the Robotaxi Race Heats Up
- 3 Waste Stocks Turning AI Investments into Growth
- 3 Overlooked Tech ETFs That Are Quietly Killing It This Year
- 3 ETFs Pairing Market-Beating Returns With High Dividend Yields
Receive News & Ratings for Trupanion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion and related companies with MarketBeat.com's FREE daily email newsletter.
